A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis

Conditions:   Polymyositis;   Dermatomyositis Interventions:   Drug: KZR-616;   Drug: Placebo Sponsor:   Kezar Life Sciences, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials